Red and near-infrared–emitting fabric clothing may improve symptoms of mild psoriasis, polymorphous light eruption (PMLE), and alopecia areata (AA), but further research with larger groups is needed ...

Psoriasis symptoms can feel like a dark cloud hovering above your head. They're pesky, sometimes even painful, making everyday life more difficult. Scalp psoriasis is a skin condition that causes the ...

Please provide your email address to receive an email when new articles are posted on . Overall psoriasis severity and scalp psoriasis, as well as itch and quality of life, were improved in patients ...

Over 60 million people worldwide are affected by psoriasis, a chronic inflammatory skin disorder that causes red, scaly patches and persistent itching. A new study has found that following a ...

Over 8 million adults in the U.S. experience plaque psoriasis — a chronic autoimmune disease that causes painful, raised, scaly spots on the skin. People with plaque psoriasis often employ a host of ...

About 7.5 million Americans have psoriasis. But, despite psoriasis being a fairly common skin condition, it's often misunderstood. In case you're not familiar with it, psoriasis is a condition that ...

This prospective multicentre study included 78 patients with mild psoriasis without musculoskeletal symptoms who were not on systemic treatment; 82% of them had mild disease and 39.7% presented with ...

Over-the-counter steroid creams like hydrocortisone can help manage mild psoriasis symptoms. Coal tar preparations may clear your skin but can cause irritation and have an unpleasant odor.

Please provide your email address to receive an email when new articles are posted on . Psoriasis is “mostly mild” in patients with psoriatic arthritis yet still impacts quality of life when measured ...

Ever since Amgen bought Celgene’s psoriasis drug Otezla for an eye-popping $13.4 billion last summer, the company has been promising investors it would find enough new markets for the drug to justify ...

Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, ...